Home › Breast Cancer › NCT05386719

Cardiometabolic Screening Program

A Cardiometabolic Screening Program for Breast Cancer Survivors

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Diagnosis of early stage breast cancer
* Completed local and/or systemic therapy at least 3 months ago
* Receiving medical oncology care at through the breast cancer clinics at Johns Hopkins Medical Institute, including the Sidney Kimmel Comprehensive Cancer Center in Baltimore MD and Green Spring Station in Lutherville-Timonium MD, and Sibley Memorial Hospital in Washington D.C.
* Read and speak English

Exclusion Criteria:

* Metastatic breast cancer

About the study

This research study is being done to implement a screening program for prediabetes, diabetes, dyslipidemia and/or hyperlipidemia, and higher risk of cardiovascular disease in breast cancer survivors. This program will also help to direct individuals with risk factors to community and institutional resources for management.

What is being tested

• Prescreening (other)
• Screening and Enrollment (other)
• Baseline (behavioral)
• Interpret BMI (behavioral)
• Interpret HbA1c (other)
• Interpret lipid panel and assess other risk factors (other)

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Participants: 450 · Started: Jun 3, 2022

Contact the study team

• Hopkins Breast Trials · Phone: 410-614-1361
• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Phone: 410-955-8804

Official record on ClinicalTrials.gov — NCT05386719

Locations in the U.S.

Conditions

• Breast Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.